Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Phase 1 × Active not recruiting × AZD9833 × Clear all

Phase

Phase 3 2 Phase 2 1 Phase 1/2 1 Phase 1 1

Status

Completed 7 Active not recruiting 1

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Breast Neoplasms 1

Interventions

pembrolizumab 88 Cyclophosphamide 77 Nivolumab 59 fludarabine 50 Specimen Handling 48 Magnetic Resonance Spectroscopy 42 Carboplatin 42 Biopsy 37 Radiotherapy 31 fludarabine phosphate 29 Gemcitabine 28 Paclitaxel 27 Ipilimumab 26 Cisplatin 26 atezolizumab 25 Radiation 23 venetoclax 22 Radiosurgery 22 Dexamethasone 22 Rituximab 19 durvalumab 18 Temozolomide 18 Lenalidomide 18 Bevacizumab 18 Decitabine 17 Pemetrexed 16 130-nm albumin-bound paclitaxel 16 palbociclib 15 Oxaliplatin 15 Fluorouracil 15

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT03616587 2026-01-28

SERENA-1

AstraZeneca

Phase 1 Active not recruiting

Breast Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon ⚡